A Corrigendum on Placebo and Nocebo in Schizophrenia: Refining the Evidence
A corrigendum has been published for a narrative review on placebo and nocebo phenomena in schizophrenia spectrum disorders. The original article, published in Psychological Medicine, synthesized current knowledge on how positive and negative expectations can influence treatment outcomes and symptom presentation in conditions like schizophrenia and psychosis. This formal correction ensures the academic record is accurate, which is critical for clinicians and researchers relying on this review to inform their understanding of non-pharmacological treatment factors, psychopharmacology trial design, and trauma-informed care approaches.
Why it might matter to you: For professionals in psychiatry and mental health, understanding the powerful role of patient expectations is essential for optimizing therapeutic alliances and interpreting clinical trial data. This corrected review underscores the need for methodological rigor when evaluating psychosocial interventions and psychopharmacology for major depression, anxiety disorders, and psychosis. It highlights an evidence-based dimension of care that directly intersects with clinical practice and research on cognitive behavioral therapy (CBT) and other modalities.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
